Old Web
English
Sign In
Acemap
>
authorDetail
>
Jingliang Xing
Jingliang Xing
Fourth Military Medical University
Hepatocellular carcinoma
Hazard ratio
Medicine
Internal medicine
Pathology
2
Papers
18
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Adjuvant 131I-metuximab for hepatocellular carcinoma after liver resection: a randomised, controlled, multicentre, open-label, phase 2 trial
2020
The Lancet Gastroenterology & Hepatology
Jun Li
Jingliang Xing
Yefa Yang
Jingfeng Liu
Wentao Wang
Yong Xia
Zhenlin Yan
Kui Wang
Dong Wu
Lu Wu
Xuying Wan
Tian Yang
Chunfang Gao
Anfeng Si
Hongyang Wang
Meng Chao Wu
Wan-yee Lau
Zhi-Nan Chen
Feng Shen
Show All
Source
Cite
Save
Citations (11)
Genetic variants in the EPCAM gene is associated with the prognosis of transarterial chemoembolization treated hepatocellular carcinoma with portal vein tumor thrombus.
2014
PLOS ONE
Xiaohe Yu
Naijian Ge
Xu Guo
Shuqun Shen
Jun Liang
Xiaojun Huang
Shaogui Wan
Jingliang Xing
Qichao Huang
Yefa Yang
Show All
Source
Cite
Save
Citations (7)
1